Fujifilm Irvine Scientific Opens European Manufacturing Facility

Fujifilm Irvine Scientific announced on Dec. 8, 2021, that it’s new manufacturing facility in Tilburg, the Netherlands, is now open and fully operational. This life science manufacturing facility joins existing locations in the United States and Japan to enable increased production capacity of cell culture media products.

The facility occupies approximately 13,500 m² of space previously used to manufacture film rolls. It manufactures dry powder media, liquid media, buffers, and water for injection. At present, it will increase production capacity with approximately 320,000 kg/year of dry powder media and more than 470,000 L/year of liquids, while also having the physical capacity to expand further.

Fujifilm’s long-term plan is to secure requisite production capacity to meet the growing needs of the market and customers worldwide. By placing their third facility in central Europe, it can act as a hub. The facility can not only be a source of local supply, increasing efficiency and cost-savings in shipping, but also secure the supply chain.

"We worked steadily to achieve milestones for construction, validation, and commissioning of this manufacturing facility," said Yutaka Yamaguchi, chairman and CEO, Fujifilm Irvine Scientific, in the press release. "Even with the global challenges faced in recent years, [Fujifilm] Irvine Scientific was determined to provide customers in Europe with local service that strengthens the supply chain and increases manufacturing capacity. It is extremely rewarding to see this commitment realized."

The site is working towards a CO2-neutral status, using wind energy for the product process, and using sustainable technologies such as membrane bioreactors for wastewater purification. It intends to become an International Organization for Standardization 13485 certified manufacturing facility and follow Current Good Manufacturing Practices, 21 Code of Federal Regulations 820 for product manufacturing.

Source: Fujifilm